The New York City Cognitive Behavioral Therapy Association Presents:
A Transdiagnostic Treatment for Anxiety & Emotional Disorders: the Unified Protocol
By
Dr. David H. Barlow, Ph.D., ABPP,
Professor of Psychology and Psychiatry Emeritus, Boston University
Founder, Center for Anxiety and Related Disorders
Thursday, June 10th, 2021
9:00AM - 1:00PM EDT
Non - Members Register Here
Members save $50 and Register Here
Students save $60 and Register Here
Student Members save $75 and Register Here
NYS CE credits are available for Social Workers, Psychologists, Creative Arts Therapists, and Licensed Psychoanalysts
Established professionals, early career professionals, and students from all applied, research, and academic settings are invited to attend.
Topic Description:
Recent conceptualizations of anxiety, depressive, trauma-related and other “emotional” disorders emphasize their similarities rather than their differences. In response, there has been a movement away from traditional disorder-specific interventions toward treatment approaches focused on addressing core psychological processes that cut across these disorders. These “transdiagnostic” treatments also address co-occurring emotional disorders, which is the norm rather than the exception, and have the potential to increase the availability of evidence-based treatments to meet a significant public health need. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (Barlow et al., 2018; UP), has accumulated substantial empirical support for its use. The UP is an emotion-focused cognitive-behavioral treatment (CBT) that targets core temperamental characteristics , particularly, but not limited to, neuroticism occurring across what used to be called the “neurotic spectrum” (e.g., anxiety, depressive, dissociative, and related disorders).
This introductory workshop will first briefly discuss the rationale for a transdiagnostic approach to treatment and review evidence supporting the UP. This will be followed by a description and demonstration of how to apply core UP treatment modules, along with the similarities and differences between the UP and traditional CBT. Audio and videotaped illustrations of core treatment interventions (e.g., mindful awareness, emotion exposures) will be presented and attendees will be invited to participate in exercises as part of these demonstrations.
You will learn:
1. How to define core temperamental characteristics and deficits in emotion regulation underlying all anxiety, depressive, and related disorders and conceptualize a case from the UP’s transdiagnostic framework.
2. How to create a treatment plan and apply the UP’s 5 core emotion-focused treatment strategies (increasing mindful emotion awareness, fostering cognitive flexibility, identifying and reducing patterns of emotion avoidance, increasing awareness and tolerance of emotion-related physical sensations, and interoceptive and situational emotion-focused exposures) to patients presenting with comorbid emotional disorders.
3. How to create effective and cohesive emotion exposures for patients with anxiety, depression and complex comorbidities.
Speaker Bio:
David H. Barlow is Professor of Psychology and Psychiatry Emeritus and Founder of the Center for Anxiety and Related Disorders at Boston University. He has published over 650 articles and chapters and over 90 books and clinical manuals mostly in the area of the nature and treatment of emotional disorders. His books and manuals have been translated in over 20 languages, including Arabic, Chinese, Hindi, Japanese and Russian. He is the recipient of numerous awards, including honorary degrees from the University of Vermont and William James College, and the two highest awards in psychology, the Distinguished Scientific Award for Applications of Psychology from the American Psychological Association and James McKeen Cattell Fellow Award from the Association for Psychological Science honoring individuals for their lifetime of significant intellectual achievements in applied psychological research. He was a member of the DSM-IV Task Force of the American Psychiatric Association, and his research has been continually funded by the National Institutes of Health for over 50 years.